Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer-Reference-Cited by-同舟云学术

Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer

Published:2020-03-31 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Shang Hongxia,Zhao Junyu,Yao Jinming,Wang Huanjun,Dong Jianjun,Liao Lin

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference51 articles.

1. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors;Pellegriti;J Cancer Epidemiol,2013

2. Targeted therapies in advanced differentiated thyroid cancer;Carneiro;Cancer Treat Rev,2015

3. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis;Brenner;Lancet,2002

4. Molecular targeted therapies of aggressive thyroid cancer;Ferrari;Front Endocrinol,2015

5. Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression;Li;Biochem Biophys Res Commun,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor mechanism of Saikosaponin A in the Xiaoying Sanjie Decoction for treatment of anaplastic thyroid cancer by network pharmacology analysis and experiments in vitro and in vivo;Fitoterapia;2023-10

2. Association between Combination Antiretroviral Therapy and Telomere Length in People Living with Human Immunodeficiency Virus;Biology;2023-09-05

3. Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer;Medical Oncology;2023-07-31

4. Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy;Drug Resistance Updates;2023-05

5. An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na+/I− Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells;Cells;2023-02-01